HK1208223A1 - 用於治療病毒感染的 -三嗪衍生物 - Google Patents

用於治療病毒感染的 -三嗪衍生物

Info

Publication number
HK1208223A1
HK1208223A1 HK15108914.9A HK15108914A HK1208223A1 HK 1208223 A1 HK1208223 A1 HK 1208223A1 HK 15108914 A HK15108914 A HK 15108914A HK 1208223 A1 HK1208223 A1 HK 1208223A1
Authority
HK
Hong Kong
Prior art keywords
treatment
viral infections
triazine derivatives
triazine
derivatives
Prior art date
Application number
HK15108914.9A
Other languages
English (en)
Inventor
‧跟巴斯
‧朱博
‧瓦羅
‧勒瓦謝
‧邦凡蒂
‧麥克格文
‧吉耶蒙
Original Assignee
Centre Nat Rech Scient
Univ Rouen
Inst Nat Sciences Appliq
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Rouen, Inst Nat Sciences Appliq filed Critical Centre Nat Rech Scient
Publication of HK1208223A1 publication Critical patent/HK1208223A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK15108914.9A 2012-10-01 2015-09-11 用於治療病毒感染的 -三嗪衍生物 HK1208223A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306196.2A EP2712866A1 (en) 2012-10-01 2012-10-01 1,2,4-triazine derivatives for the treatment of viral infections
PCT/EP2013/070488 WO2014053516A1 (en) 2012-10-01 2013-10-01 1,2,4-triazine derivatives for the treatment of viral infections.

Publications (1)

Publication Number Publication Date
HK1208223A1 true HK1208223A1 (zh) 2016-02-26

Family

ID=46982496

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15108914.9A HK1208223A1 (zh) 2012-10-01 2015-09-11 用於治療病毒感染的 -三嗪衍生物

Country Status (22)

Country Link
US (1) US9416114B2 (zh)
EP (2) EP2712866A1 (zh)
JP (1) JP6298998B2 (zh)
KR (1) KR102138393B1 (zh)
CN (1) CN104812747B (zh)
AU (1) AU2013326579B2 (zh)
BR (1) BR112015007310B1 (zh)
CA (1) CA2886630C (zh)
CL (1) CL2015000787A1 (zh)
EA (1) EA026236B1 (zh)
ES (1) ES2616496T3 (zh)
HK (1) HK1208223A1 (zh)
IL (1) IL237871A (zh)
IN (1) IN2015DN03327A (zh)
MX (1) MX348229B (zh)
MY (1) MY182558A (zh)
NZ (1) NZ706354A (zh)
PH (1) PH12015500724A1 (zh)
SG (1) SG11201502522WA (zh)
UA (1) UA114644C2 (zh)
WO (1) WO2014053516A1 (zh)
ZA (1) ZA201502240B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102058946B1 (ko) 2011-04-08 2019-12-24 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 바이러스 감염 치료를 위한 피리미딘 유도체
BR112014011162A2 (pt) 2011-11-09 2017-05-09 Janssen R&D Ireland derivados purínicos para o tratamento de infecções virais
CN104703990B (zh) 2012-07-13 2017-10-13 爱尔兰詹森科学公司 用于治疗病毒性感染的大环嘌呤
EA202090662A3 (ru) 2012-10-10 2020-08-31 Янссен Сайенсиз Айрлэнд Юси ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-d]ПИРИМИДИНА ДЛЯ ЛЕЧЕНИЯ ВИРУСНЫХ ИНФЕКЦИЙ И ДРУГИХ ЗАБОЛЕВАНИЙ
NZ706226A (en) 2012-11-16 2019-09-27 Janssen Sciences Ireland Uc Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
WO2014128189A1 (en) 2013-02-21 2014-08-28 Janssen R&D Ireland 2-aminopyrimidine derivatives for the treatment of viral infections
SG11201508078XA (en) 2013-03-29 2015-11-27 Janssen Sciences Ireland Uc Macrocyclic deaza-purinones for the treatment of viral infections
KR102280559B1 (ko) 2013-05-24 2021-07-22 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 바이러스 감염 및 추가적인 질환의 치료를 위한 피리돈 유도체
EA034893B1 (ru) 2013-06-27 2020-04-02 Янссен Сайенсиз Айрлэнд Юси Производные пирроло[3,2-d]пиримидина для лечения вирусных инфекций и других заболеваний
CN105492446B (zh) 2013-07-30 2018-08-03 爱尔兰詹森科学公司 用于治疗病毒性感染的噻吩并[3,2-d]嘧啶衍生物
WO2018002319A1 (en) 2016-07-01 2018-01-04 Janssen Sciences Ireland Uc Dihydropyranopyrimidines for the treatment of viral infections
US10968184B2 (en) * 2016-09-29 2021-04-06 Janssen Sciences Ireland Unlimited Company Pyrimidine prodrugs for the treatment of viral infections and further diseases
TW201945003A (zh) 2018-03-01 2019-12-01 愛爾蘭商健生科學愛爾蘭無限公司 2,4-二胺基喹唑啉衍生物及其醫學用途
BR112021015577A8 (pt) 2019-02-08 2021-10-05 Research & Business Found Sungkyunkwan Univ Complexo-colesterol agonista do receptor toll-like 7/8, composição de nanopartícula, composição adjuvante, composição de vacina, composição para regular uma função imunológica, composição farmacêutica e uso do complexo
CN115666637A (zh) 2020-03-02 2023-01-31 蛋白科技先锋 基于病原体细胞壁骨架的模拟活病原体的纳米粒子及其制备方法
EP4194010A1 (en) 2020-08-04 2023-06-14 Progeneer Inc. Conjugate of functional drug and toll-like receptor 7 or 8 agonist of which active site is temporarily inactivated and use thereof
WO2022031011A1 (ko) 2020-08-04 2022-02-10 성균관대학교산학협력단 동력학적으로 작용하는 아주번트 앙상블
JP2023536953A (ja) 2020-08-04 2023-08-30 プロジェニア インコーポレイテッド 動力学的制御が可能なアジュバントを含むmRNAワクチン

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485531A1 (fr) * 1980-06-25 1981-12-31 Fabre Sa Pierre Nouveaux n-oxydes de diaryl-5,6 as triazines 1-2-4, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
WO1998001448A1 (fr) 1996-07-03 1998-01-15 Japan Energy Corporation Nouveaux derives de purine
WO1999028321A1 (fr) 1997-11-28 1999-06-10 Sumitomo Pharmaceuticals Company, Limited Nouveaux composes heterocycliques
CN101035773B (zh) * 2004-08-10 2012-06-06 詹森药业有限公司 抑制hiv的1,2,4-三嗪-6-酮衍生物
CN101203519A (zh) 2005-05-04 2008-06-18 辉瑞有限公司 用于治疗癌症和病毒感染如丙型肝炎的用作Toll样受体调节剂的2-酰氨基-6-氨基-8-氧代嘌呤衍生物
CA2619919C (en) * 2005-09-01 2014-04-01 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 modulators
RU2352565C1 (ru) * 2007-10-08 2009-04-20 Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" 3-амино-6-ароилметил-5-гидрокси-1,2,4-триазины и способ их получения
PE20091236A1 (es) 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
WO2012067269A1 (en) * 2010-11-19 2012-05-24 Dainippon Sumitomo Pharma Co., Ltd. Aminoalkoxyphenyl compounds and their use in the treatment of disease

Also Published As

Publication number Publication date
KR20150084791A (ko) 2015-07-22
CA2886630C (en) 2021-01-26
IN2015DN03327A (zh) 2015-10-09
WO2014053516A1 (en) 2014-04-10
BR112015007310B1 (pt) 2022-07-19
MY182558A (en) 2021-01-25
JP6298998B2 (ja) 2018-03-28
CA2886630A1 (en) 2014-04-10
AU2013326579B2 (en) 2017-04-27
CN104812747B (zh) 2017-03-08
US20150336907A1 (en) 2015-11-26
PH12015500724B1 (en) 2015-06-01
EP2903976B1 (en) 2016-12-07
UA114644C2 (uk) 2017-07-10
KR102138393B1 (ko) 2020-08-14
JP2015535839A (ja) 2015-12-17
US9416114B2 (en) 2016-08-16
NZ706354A (en) 2018-08-31
SG11201502522WA (en) 2015-05-28
MX2015004160A (es) 2016-02-05
MX348229B (es) 2017-05-31
PH12015500724A1 (en) 2015-06-01
ZA201502240B (en) 2016-05-25
CL2015000787A1 (es) 2015-10-02
AU2013326579A1 (en) 2015-04-09
CN104812747A (zh) 2015-07-29
EA026236B1 (ru) 2017-03-31
ES2616496T3 (es) 2017-06-13
BR112015007310A2 (pt) 2017-08-08
EP2712866A1 (en) 2014-04-02
EP2903976A1 (en) 2015-08-12
IL237871A (en) 2017-04-30
EA201500383A1 (ru) 2015-07-30

Similar Documents

Publication Publication Date Title
HK1208223A1 (zh) 用於治療病毒感染的 -三嗪衍生物
HK1256490A1 (zh) 用於治療病毒感染的嘧啶衍生物
ZA201405820B (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
HK1211589A1 (zh) 用於治療副粘病毒病毒性感染的化合物
ZA201603123B (en) Pyrrolo [1,2,f] [1,2,4] triazines useful for treating respiratory syncitial virus infections
HK1213569A1 (zh) 用於治療病毒性感染的 -氨基嘧啶衍生物
ZA201500921B (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diaseases
SG11201503042QA (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
IL240765A0 (en) Macrocyclic daza-furanones for the treatment of viral infections
ZA201306342B (en) The treatment of viral infections
TH1501001789A (th) อนุพันธ์ของ 1,2,4-ไตรอะซีน สำหรับการบำบัดของโรคติดเชื้อไวรัส

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231001